Press

A core objective of BRIGHT is to share our results, progress, and to increase the knowledge about Bilharzia.

In order to see the latest news about BRIGHT: News section

Do you want to know what we are doing?

Follow us on Twitter.

 

A collection of high resolution downloadable photographs of the people of BRIGHT and our work can be found in our photo gallery.

For more questions please contact our communication officer:

Ida Amelie Mayes: [email protected]

South Africa no: (+27) 76 692 819

Norwegian no: (+47) 906 56 702


Follow on social media

Although the situations portrayed on this website are typical of the research none of the persons in this website are research patients (study participants). None of the persons portrayed in the treatment and investigative situations are minors. They have kindly given their permissions to publish the images.
Kinldy credit photographer Håvard Holme.

 


Academic day for BRIGHT PhD candidates and students

PhD Candidates Pavitra Pillay, Nonhlanhla Mbathi and Dr Hashini Galappaththi-Arachchige presented their work, as well as practical and ethical aspects of research on reproductive tract disease. Masters Student and Teacher Edmore Mazani discussed his protocol for use in rural schools and Dr Sigve Holmen (PhD Candidate), Harding Hospital, presented possibilities for diagnostic tools. Our former Masters Student Adele Munsami, now PhD Candidate at CAPRISA presented her upcoming article from the Departments of Psychology and Public Health whilst academic Assistant Lea Nga Tran (MEcon) presented data on teenagers and their willingness to participate in research.               Four medical students from Norway visited the project together with Professor Borghild Roald. They did their very first presentations in English and did well: Lynn Duong, Cornelia Kristiansen, Kristine Hjetland and Ingunn... read more

PhD thesis on HIV susceptibility related to HIV target cells and cervical ectopy

A study of South African women living in a rural area endemic of urogenital schistosomiasis. PhD Candidate Elisabeth Kleppa of University of Oslo successfully defended her PhD with opponents Agnes Chenine and Per Kallestrup. More than 110 million Africans are estimated to be infected with Schistosoma (S.) haematobium, but it is still one of the so-called “neglected tropical diseases”. Poor countries bear the majority of the disease burden, contributing to the maintenance of the cycle of poverty. In Africa, women are at a higher risk of human immunodeficiency virus (HIV) infection than men, and this cannot be explained by behavioural factors alone. Biological risk factors seem to contribute to the differences in HIV prevalence between geographical regions and genders. This thesis will focus on female genital schistosomiasis and cervical ectopy, both factors hypothesised to facilitate the transmission of HIV through the genital mucosa. Genital schistosomiasis in women is characterized by lesions referred to as “sandy patches” that appear grainy or homogenous and are thought to be caused by the deposition of ova in the genital tissues. Sandy patches are often associated with abnormal mucosal blood vessels and contact bleeding due to the fragile mucosa. Cervical ectopy and female genital schistosomiasis (FGS) may be diagnosed by photocolposcopic examination, and both conditions are likely to be present before sexual debut. In addition to increased susceptibility to HIV infection, S. haematobium infection has been suggested to accelerate the progression of HIV infection, possibly through increased immune activation. In this study, South African women attending high schools in KwaZulu-Natal were included. Blood, urine and cervical lavage samples were collected and a photocolposcopic examination... read more

Funding for Ebola hides decline in funding

Public funding for neglected disease research and development was actually at its lowest level in seven years, with public funding for non-Ebola R&D dropping by $62m in 2014. As the world’s biggest funder of neglected disease R&D, much of this decline has been driven by the US Government. US Government funding for non-Ebola neglected disease R&D fell again in 2014 – further extending the large sequester-related cuts of the previous year – to be nearly a quarter of a billion dollars ($221m) below its 2009... read more
(Page 8 of 12)« First...678910...Last »

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.